Skip to content
healthcare.dev
Get a free key

QUALITY CHOICE Nausea Relief

NDC 83324-300, Sodium Citrate dihydrate, tablet, chewable, from QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION).

Product NDC
83324-300
Status
Listed
Labeler
QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83324-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRISODIUM CITRATE DIHYDRATE230 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
83324-300-42833240300423 BLISTER PACK in 1 CARTON (83324-300-42) / 14 TABLET, CHEWABLE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83324-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83324-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83324-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.